| Literature DB >> 26807908 |
Sam Young Yoon1, Seok Hyun Bae1, Young Joo Shin1, Shin Goo Park2, Sang-Hee Hwang3, Joon Young Hyon4,5, Won Ryang Wee4.
Abstract
BACKGROUND: Dry eye syndrome (DES) is a common tear film and ocular surface disease that results in discomfort, visual disturbance, and tear film instability with potential damage to the ocular surface. Systemic diseases associated with DES include diabetes mellitus, rheumatoid arthritis, depression, anxiety, thyroid disease, allergic diseases, irritable bowel syndrome, chronic pain syndrome, and hyperlipidemia. Interestingly, it has been found that most of these are associated with low levels of serum 25-hydroxyvitamin D (25(OH)D) or inadequate sunlight exposure.Entities:
Mesh:
Substances:
Year: 2016 PMID: 26807908 PMCID: PMC4726745 DOI: 10.1371/journal.pone.0147847
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
General characteristics of dry eye syndrome.
| Diagnosed DES (dgDES) | Symptoms of DES (sxDES) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-dgDES | dgDES | %difference | p-value | Non-sxDES | sxDES | %difference | p-value | ||||
| Total | |||||||||||
| N (%) | 15720 (89.61%) | 1822 (10.39%) | 13948 (82.21%) | 3018 (17.79%) | |||||||
| Age (y) | <0.001 | <0.001 | |||||||||
| <50 | 3453 (92.62%) | 275 (7.38%) | 6890 (83.28%) | 1383 (16.72%) | |||||||
| ≥50 | 12267 (88.80%) | 1547 (11.20%) | 41.12 | 7058 (81.19%) | 1635 (18.81%) | 11.76 | |||||
| Gender | <0.001 | <0.001 | |||||||||
| Male | 7023 (94.47%) | 411 (5.53%) | 6343 (88.50%) | 824 (11.50%) | |||||||
| Female | 8697 (86.04%) | 1411 (13.96%) | 86.51 | 7605 (77.61%) | 2194 (22.39%) | 64.27 | |||||
| Obesity | 0.430 | 0.058 | |||||||||
| Non-obese | 7702 (89.88%) | 869 (10.12%) | 6868 (82.83%) | 1424 (17.17%) | |||||||
| Obese | 3594 (89.40%) | 426 (10.60%) | 4.63 | 3160 (81.42%) | 721 (18.58%) | 7.89 | |||||
| Diabetes mellitus | 0.713 | 0.927 | |||||||||
| Non-DM | 10078 (89.57%) | 1174 (10.43%) | 8935 (82.21%) | 1933 (17.79%) | |||||||
| IFG | 2681 (89.70%) | 308 (10.30%) | 1.25 | 2381 (82.10%) | 519 (17.90%) | 0.62 | |||||
| DM | 1486 (90.22%) | 161 (9.78%) | 6.43 | 1316 (82.56%) | 278 (17.44%) | 1.99 | |||||
| Rheumatoid arthritis | <0.001 | 0.051 | |||||||||
| Non-RA | 14909 (89.75%) | 1702 (10.25%) | 13218 (82.26%) | 2851 (17.74%) | |||||||
| RA | 368 (84.21%) | 69 (15.79%) | 42.55 | 330 (78.57%) | 90 (21.43%) | 18.84 | |||||
| Depression | <0.001 | <0.001 | |||||||||
| Non-depression | 13068 (90.40%) | 1387 (9.60%) | 11659 (83.42%) | 2317 (16.58%) | |||||||
| Depression | 2210 (85.20%) | 384 (14.80%) | 42.62 | 1889 (75.17%) | 624 (24.83%) | 39.85 | |||||
| Thyroid disorder | <0.001 | <0.001 | |||||||||
| Non-thyroid disorder | 14710 (90.02%) | 1630 (9.98%) | 13054 (82.59%) | 2752 (17.41%) | |||||||
| Thyroid disorder | 567 (80.08%) | 141 (19.92%) | 66.49 | 493 (72.29%) | 189 (27.71%) | 45.66 | |||||
| History of ocular surgery | <0.001 | <0.001 | |||||||||
| No | 13435 (91.02%) | 1326 (8.98%) | 11999 (84.00%) | 2285 (16.00%) | |||||||
| Yes | 2130 (81.86%) | 472 (18.14%) | 67.55 | 1831 (72.72%) | 687 (27.28%) | 52.12 | |||||
| Atopic dermatitis | 0.634 | 0.187 | |||||||||
| Non-AD | 14590 (89.64%) | 1687 (10.36%) | 12944 (82.25%) | 2793 (17.75%) | |||||||
| AD | 688 (89.12%) | 84 (10.88%) | 4.90 | 604 (80.32%) | 148 (19.68%) | 10.31 | |||||
| Region of residence | <0.001 | <0.001 | |||||||||
| Urban | 12267 (88.80%) | 1547 (11.20%) | 10933 (81.67%) | 2453 (18.33%) | |||||||
| Rural | 3453 (92.62%) | 275 (7.38%) | 41.12 | 3015 (84.22%) | 565 (15.78%) | 14.95 | |||||
| Occupation | <0.001 | <0.001 | |||||||||
| Indoor | 11091 (88.30%) | 1470 (11.70%) | 9821 (80.86%) | 2325 (19.14%) | |||||||
| Outdoor | 4128 (93.29%) | 297 (6.71%) | 54.21 | 3676 (85.83%) | 607 (14.17%) | 29.84 | |||||
| Sunlight exposure time (h) | <0.001 | <0.001 | |||||||||
| Sufficient (≥ 5) | 2194 (93.24%) | 159 (6.76%) | 1906 (84.34%) | 354 (15.66%) | |||||||
| Inadequate (2–5) | 3707 (90.68%) | 381 (9.32%) | 31.84 | 3292 (83.32%) | 659 (16.68%) | 6.31 | |||||
| Deficient (< 2) | 9790 (88.45%) | 1278 (11.55%) | 52.32 | 8722 (81.35%) | 2000 (18.65%) | 17.43 | |||||
| Regular exercise | 0.043 | 0.014 | |||||||||
| No | 13929 (89.44%) | 1644 (10.56%) | 12336 (81.93%) | 2721 (18.07%) | |||||||
| Yes | 1318 (91.15%) | 128 (8.85%) | 17.62 | 1182 (84.55%) | 216 (15.45%) | 15.63 | |||||
| Walking exercise | 0.062 | 0.048 | |||||||||
| No | 9431 (89.24%) | 1137 (10.76%) | 8340 (81.68%) | 1871 (18.32%) | |||||||
| Yes | 5800 (90.15%) | 634 (9.85%) | 8.83 | 5164 (82.90%) | 1065 (17.10%) | 6.89 | |||||
| Serum zinc level (μg/dL) | 0.091 | 0.004 | |||||||||
| >110 | 742 (45.00%) | 907 (55.00%) | 624 (79.29%) | 163 (20.71%) | |||||||
| <110 | 89 (51.74%) | 83 (48.26%) | 13.05 | 801 (84.67%) | 145 (15.33%) | 29.86 | |||||
| Serum 25(OH)D level (ng/mL) | <0.001 | 0.001 | |||||||||
| Adequate (≥20) | 4390 (91.29%) | 419 (8.71%) | 3866 (83.68%) | 754 (16.32%) | |||||||
| Inadequate (12–20) | 7892 (89.38%) | 938 (10.62%) | 19.76 | 7071 (82.35%) | 1516 (17.65%) | 7.83 | |||||
| Deficient (<12) | 2601 (60.39%) | 1706 (39.61%) | 127.89 | 2271 (80.13%) | 563 (19.87%) | 19.62 | |||||
*statistically significant by chi-square test
DES = dry eye syndrome; DM = diabetes mellitus; IFG = impaired fasting glucose; RA = rheumatoid arthritis; AD = atopic dermatitis
Serum 25(OH)D levels and zinc levels between groups.
| Diagnosed DES (dgDES) | Symptoms of DES (sxDES) | |||||
|---|---|---|---|---|---|---|
| Non-dgDES | dgDES | p-value | Non-sxDES | sxDES | p-value | |
| Serum 25(OH)D level (ng/mL) | 17.52 ± 6.07 | 16.90 ± 6.08 | <0.001 | 17.51 ± 6.03 | 17.12 ± 6.13 | 0.001 |
| Serum zinc levels (μg/dL) | 136.05 ± 29.58 | 131.80 ± 25.79 | 0.070 | 137.09 ± 29.45 | 131.20 ± 28.63 | 0.001 |
*statistically significant by independent t-test
25-hydroxyvitamin D = 25(OH)D; DES = dry eye syndrome
Serum 25(OH)D level (ng/mL).
| Serum 25(OH)D level (ng/mL) | p-value | |
|---|---|---|
| Age (y) | <0.001 | |
| <50 | 16.25 ± 5.26 | |
| >50 | 18.70 ± 6.46 | |
| Gender | <0.001 | |
| Male | 18.45 ± 5.97 | |
| Female | 16.49 ± 5.80 | |
| Obesity | 0.660 | |
| Non-obese | 17.37 ± 5.95 | |
| Obese | 17.32 ± 6.02 | |
| Diabetes mellitus | <0.001 | |
| Non-DM | 17.20 ± 5.94 | |
| IFG | 18.19 ± 6.09 | |
| DM | 18.25 ± 6.65 | |
| Rheumatoid arthritis | 0.041 | |
| Non-RA | 17.46 ± 6.06 | |
| RA | 18.15 ± 6.72 | |
| Depression | 0.718 | |
| Non-depression | 17.49 ± 6.01 | |
| Depression | 17.44 ± 6.18 | |
| Thyroid disorder | 0.405 | |
| Non-thyroid disorder | 17.47 ± 6.06 | |
| Thyroid disorder | 17.67 ± 6.31 | |
| History of ocular surgery | <0.001 | |
| No | 17.39 ± 5.99 | |
| Yes | 17.91 ± 6.58 | |
| Atopic dermatitis | <0.001 | |
| Non-AD | 17.52 ± 6.09 | |
| AD | 16.69 ± 5.58 | |
| Region of residence | <0.001 | |
| Rural | 19.16 ± 6.47 | |
| Urban | 16.91 ± 5.74 | |
| Occupation | <0.001 | |
| Groups 4, 5 and 6 (outdoor) | 19.22 ± 6.48 | |
| Groups 1,2,3, and 7 (indoor) | 16.73 ± 5.73 | |
| Sunlight exposure time (h) | <0.001 | |
| ≥5 | 20.16 ± 6.55 | |
| 2–5 | 17.83 ± 6.12 | |
| <2 | 16.77 ± 5.78 | |
| Regular exercise | <0.001 | |
| No | 17.31 ± 5.99 | |
| Yes | 18.66 ± 6.46 | |
| Walking exercise | <0.001 | |
| No | 17.25 ± 5.60 | |
| Yes | 17.71 ± 6.16 | |
| Serum zinc levels (μg/dL) | <0.001 | |
| ≥110 | 18.61 ± 6.49 | |
| <110 | 16.78 ± 5.81 |
* statistically significant by independent t-test
DES = dry eye syndrome; DM = diabetes mellitus; IFG = impaired fasting glucose; RA = rheumatoid arthritis; AD = atopic dermatitis
Factors that affect the occurrence of dry eye syndrome after adjusting for age and gender.
| Diagnosed DES | Symptoms of DES | |||||
|---|---|---|---|---|---|---|
| OR | 95% CI | p-value | OR | 95% CI | p-value | |
| Region of residence | ||||||
| Rural | 1.0 (ref) | 1.0 (ref) | ||||
| Urban | 1.669 | 1.456–1.913 | <0.001 | 1.243 | 1.122–1.377 | <0.001 |
| Occupation | ||||||
| Outdoor | 1.0 (ref) | 1.0 (Ref) | ||||
| Indoor | 1.587 | 1.389–1.815 | <0.001 | 1.264 | 1.143–1.399 | <0.001 |
| Obesity | ||||||
| Non-obese | 1.0 (ref) | 1.0 (ref) | ||||
| Obese | 1.069 | 0.944–1.210 | 0.291 | 1.115 | 1.008–1.232 | 0.034 |
| Diabetes mellitus | ||||||
| Non-DM | 1.0 (ref) | 1.0 (ref) | ||||
| IFG | 1.067 | 0.929–1.224 | 0.359 | 1.075 | 0.962–1.202 | 0.200 |
| DM | 0.955 | 0.796–1.145 | 0.618 | 0.998 | 0.864–1.155 | 0.984 |
| Rheumatoid arthritis | ||||||
| Non-RA | 1.0 (ref) | 1.0 (ref) | ||||
| RA | 1.026 | 0.969–1.085 | 0.380 | 1.025 | 0.978–1.074 | 0.299 |
| Depression | ||||||
| Non-depression | 1.0 (ref) | 1.0 (ref) | ||||
| Depression | 1.059 | 1.008–1.113 | 0.024 | 1.075 | 1.032–1.120 | 0.001 |
| Thyroid disorder | ||||||
| Non-thyroid disorder | 1.0 (ref) | 1.0 (ref) | ||||
| Thyroid disorder | 1.053 | 1.000–1.109 | 0.051 | 1.046 | 1.001–1.094 | 0.045 |
| History of ocular surgery | ||||||
| No | 1.0 (ref) | 1.0 (ref) | ||||
| Yes | 1.203 | 1.103–1.312 | <0.001 | 1.070 | 1.011–1.131 | 0.019 |
| Atopic dermatitis | ||||||
| Non-AD | 1.0 (ref) | 1.0 (ref) | ||||
| AD | 1.124 | 0.888–1.423 | 0.330 | 1.199 | 0.994–1.446 | 0.058 |
| Sun exposure time (h) | ||||||
| Sufficient (≥2) | 1.0 (ref) | 1.0 (ref) | ||||
| Inadequate (2–5) | 1.389 | 1.143–1.690 | 0.001 | 1.047 | 0.907–1.209 | 0.528 |
| Deficient (<2) | 1.630 | 1.367–1.944 | <0.001 | 1.119 | 0.984–1.271 | 0.085 |
| Regular exercise | ||||||
| No | 1.0 (ref) | 1.0 (ref) | ||||
| Yes | 0.841 | 0.696–1.108 | 0.076 | 0.843 | 0.724–0.982 | 0.029 |
| Walking exercise | ||||||
| No | 1.0 (ref) | 1.0 (ref) | ||||
| Yes | 0.959 | 0.865–1.064 | 0.434 | 0.961 | 0.884–1.045 | 0.353 |
| Serum 25(OH)D level (ng/mL) | ||||||
| Adequate (≥20) | 1.0 (ref) | 1.0 (ref) | ||||
| Inadequate (12–20) | 1.167 | 1.030–1.321 | 0.015 | 1.036 | 0.939–1.143 | 0.483 |
| Deficient (<12) | 1.205 | 1.031–1.407 | 0.019 | 1.113 | 0.982–1.262 | 0.094 |
| Serum zinc level (μg/dL) | ||||||
| ≥110 | 1.0 (ref) | 1.0 (ref) | ||||
| <110 | 0.926 | 0.671–1.278 | 0.638 | 0.798 | 0.620–1.029 | 0.081 |
*statistically significant by logistic regression analysis
DES = dry eye syndrome; OR = odds ratio; CI = Confidence interval; DM = diabetes mellitus; IFG = impaired fasting glucose; RA = rheumatoid arthritis; AD = atopic dermatitis
Relationship of serum 25-hydroxyvitamin D level and dry eye syndrome.
| Diagnosed DES | Symptoms of DES | |||||
|---|---|---|---|---|---|---|
| OR | 95% CI | p-value | OR | 95% CI | p-value | |
| Sunlight exposure time (h) | ||||||
| Sufficient (≥2) | 1.0 (ref) | 1.0 (ref) | ||||
| Inadequate (2–5) | 1.142 | 0.882–1.479 | 0.314 | 0.978 | 0.809–1.182 | 0.815 |
| Deficient (<2) | 1.383 | 1.094–1.749 | 0.007 | 1.050 | 0.885–1.246 | 0.575 |
| Serum 25(OH)D level (ng/mL) | ||||||
| Adequate (≥20) | 1.0 (ref) | 1.0 (ref) | ||||
| Inadequate (12–20) | 1.178 | 1.010–1.372 | 0.036 | 1.045 | 0.926–1.179 | 0.475 |
| Deficient (<12) | 1.216 | 1.007–1.469 | 0.043 | 1.115 | 0.957–1.298 | 0.163 |
Adjusted by age, sex, obesity, diabetes mellitus, rheumatoid arthritis, depression, thyroid disorder, atopic dermatitis, history of ocular surgery, regular exercise, occupation and residence. 25-hydroxyvitamin D = 25(OH)D; DES = dry eye syndrome; OR = odds ratio; CI = Confidence interval
*statistically significant by logistic regression analysis